docetaxel anhydrous has been researched along with galbanic acid in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (galbanic acid) | Trials (galbanic acid) | Recent Studies (post-2010) (galbanic acid) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 33 | 0 | 23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abnous, K; Afsharzadeh, M; Babaei, M; Hashemi, M; Ramezani, M | 1 |
1 other study(ies) available for docetaxel anhydrous and galbanic acid
| Article | Year |
|---|---|
PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
Topics: Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cell Survival; Coumarins; Docetaxel; Drug Carriers; Drug Compounding; Drug Liberation; Glutamate Carboxypeptidase II; Glutarates; Humans; Ligands; Male; Nanoparticles; PC-3 Cells; Polyethylene Glycols; Prostatic Neoplasms | 2020 |